Perfecting Dose Response Assays

Jeffrey Weidner and Eric Niederkofler will discuss strategies for optimizing dose response assays.

Event Details:Perfecting Dose Response Assays Date(s):

FREE Webinar

Thursday, February 25, 2021
2:30- 4:00 PM Eastern Time

Register Now

Researchers performing basic research and developing therapeutics carefully assess the biological mechanisms and toxicity of novel molecules. Dose response assays are indispensable when determining the appropriate dose for in vitro or in vivo applications; however, researchers must perform these experiments with accuracy and precision to produce reliable results. In this webinar brought to you by Thermo Fisher Scientific, Jeffrey Weidner will discuss how to design ideal dose response assays, and Eric Niederkofler will highlight how automated liquid handlers simplify dose response assays.

Topics to be covered

Register Now

Meet the Speakers:

Jeffrey Weidner, PhD
Founder
QualSci Consulting, LLC

Eric Niederkofler, PhD
Applications Manager
Thermo Fisher Scientific



genomics.png

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies